{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:57:00Z","timestamp":1789077420796,"version":"build-2803163510"},"reference-count":37,"publisher":"American Association for Cancer Research (AACR)","issue":"19","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diffuse malignant mesothelioma (DMM) is a tumor of serosal membranes with propensity for progressive local disease. Because current treatment options are largely ineffective, novel therapeutic strategies based on molecular mechanisms and the disease characteristics are needed to improve the outcomes of patients with this disease. Akt kinase interacting protein 1 (Aki1; Freud-1\/CC2D1A) is a scaffold protein for the PI3K\u2013PDK1\u2013Akt signaling module that helps determine receptor signal selectivity for EGFR. Aki1 has been suggested as a therapeutic target, but its potential has yet to be evaluated in a tumor setting. Here, we report evidence supporting its definition as a therapeutic target in DMM. In cell-based assays, Aki1 silencing decreased cell viability and caused cell-cycle arrest of multiple DMM cell lines via effects on the PKA\u2013CREB1 signaling pathway. Blocking CREB activity phenocopied Aki1 silencing. Clinically, Aki1 was expressed in most human DMM specimens where its expression correlated with phosphorylated CREB1. Notably, Aki1 siRNA potently blocked tumor growth in an orthotopic implantation model of DMM when administered directly into the pleural cavity of tumor-bearing mice. Our findings suggest an important role for the Aki1\u2013CREB axis in DMM pathogenesis and provide a preclinical rationale to target Aki1 by intrathoracic therapy in locally advanced tumors. Cancer Res; 75(19); 4188\u201397. \u00a92015 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-15-0858","type":"journal-article","created":{"date-parts":[[2015,8,20]],"date-time":"2015-08-20T22:44:02Z","timestamp":1440110642000},"page":"4188-4197","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Akt Kinase-Interacting Protein 1 Signals through CREB to Drive Diffuse Malignant Mesothelioma"],"prefix":"10.1158","volume":"75","author":[{"given":"Tadaaki","family":"Yamada","sequence":"first","affiliation":[{"name":"1Department of Internal Medicine, The Ohio State University Medical Center, Columbus, Ohio."},{"name":"2Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Amann","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, The Ohio State University Medical Center, Columbus, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Fukuda","sequence":"additional","affiliation":[{"name":"2Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"2Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Fujita","sequence":"additional","affiliation":[{"name":"3Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisanori","family":"Uehara","sequence":"additional","affiliation":[{"name":"4Department of Molecular and Environmental Pathology, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Iwakiri","sequence":"additional","affiliation":[{"name":"5Department of Respiratory Surgery, Hyogo Prefectural Amagasaki Hospital, Amagasaki, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Itoi","sequence":"additional","affiliation":[{"name":"5Department of Respiratory Surgery, Hyogo Prefectural Amagasaki Hospital, Amagasaki, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Shilo","sequence":"additional","affiliation":[{"name":"6Department of Pathology, The Ohio State University Medical Center, Columbus, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Yano","sequence":"additional","affiliation":[{"name":"2Division of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Carbone","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine, The Ohio State University Medical Center, Columbus, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2015,9,30]]},"reference":[{"key":"2022061705134091000_bib1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1165\/ajrcmb.17.6.f141","article-title":"Asbestos, the mesothelial cell and malignancy: a matter of life or death","volume":"17","author":"Broaddus","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2022061705134091000_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2486\/indhealth.39.65","article-title":"Asbestos-related lung cancer and mesothelioma in Japan","volume":"39","author":"Morinaga","year":"2001","journal-title":"Ind Health"},{"key":"2022061705134091000_bib3","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N Engl J Med"},{"key":"2022061705134091000_bib4","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2174\/138945009789753200","article-title":"Molecular targets in malignant pleural mesothelioma treatment","volume":"10","author":"Pasello","year":"2009","journal-title":"Curr Drug Targets"},{"key":"2022061705134091000_bib5","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1200\/JCO.2006.09.7634","article-title":"Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study","volume":"25","author":"Garland","year":"2007","journal-title":"J Clin Oncol"},{"key":"2022061705134091000_bib6","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1158\/1078-0432.CCR-04-1940","article-title":"Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B","volume":"11","author":"Govindan","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2022061705134091000_bib7","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1200\/JCO.2006.06.3958","article-title":"Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non\u2013small cell lung cancer","volume":"24","author":"Hirsch","year":"2006","journal-title":"J Clin Oncol"},{"key":"2022061705134091000_bib8","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/bjc.2013.130","article-title":"Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma","volume":"108","author":"Mezzapelle","year":"2013","journal-title":"Br J Cancer"},{"key":"2022061705134091000_bib9","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/carcin\/bgp097","article-title":"Combined inhibition of MET and EGFR suppresses proliferation of malignant mesothelioma cells","volume":"30","author":"Kawaguchi","year":"2009","journal-title":"Carcinogenesis"},{"key":"2022061705134091000_bib10","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1128\/MCB.00114-08","article-title":"Freud-1\/Aki1, a novel PDK1-interacting protein, functions as a scaffold to activate the PDK1\/Akt pathway in epidermal growth factor signaling","volume":"28","author":"Nakamura","year":"2008","journal-title":"Mol Cell Biol"},{"key":"2022061705134091000_bib11","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1038\/onc.2012.446","article-title":"Akt kinase-interacting protein1, a novel therapeutic target for lung cancer with EGFR-activating and gatekeeper mutations","volume":"32","author":"Yamada","year":"2013","journal-title":"Oncogene"},{"key":"2022061705134091000_bib12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/MPA.0000000000000168","article-title":"Expression of Akt kinase-interacting protein 1, a scaffold protein of the PI3K\/PDK1\/Akt pathway, in pancreatic cancer","volume":"43","author":"Ohtsubo","year":"2014","journal-title":"Pancreas"},{"key":"2022061705134091000_bib13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat Rev Genet"},{"key":"2022061705134091000_bib14","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nmat3765","article-title":"Delivery materials for siRNA therapeutics","volume":"12","author":"Kanasty","year":"2013","journal-title":"Nat Mater"},{"key":"2022061705134091000_bib15","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1349-7006.2006.00386.x","article-title":"Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32","volume":"98","author":"Taniguchi","year":"2007","journal-title":"Cancer Sci"},{"key":"2022061705134091000_bib16","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/bjc.2011.400","article-title":"Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin","volume":"105","author":"Giovannetti","year":"2011","journal-title":"Br J Cancer"},{"key":"2022061705134091000_bib17","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.ajpath.2011.05.060","article-title":"Pleural mesothelioma instigates tumor-associated fibroblasts to promote progression via a malignant cytokine network","volume":"179","author":"Li","year":"2011","journal-title":"Am J Pathol"},{"key":"2022061705134091000_bib18","doi-asserted-by":"crossref","first-page":"9479","DOI":"10.1158\/0008-5472.CAN-08-1643","article-title":"Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations","volume":"68","author":"Yano","year":"2008","journal-title":"Cancer Res"},{"key":"2022061705134091000_bib19","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/JTO.0000000000000173","article-title":"LKB1 Loss induces characteristic patterns of gene expression in human tumors associated with NRF2 activation and attenuation of PI3K-AKT","volume":"9","author":"Kaufman","year":"2014","journal-title":"J Thorac Oncol"},{"key":"2022061705134091000_bib20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35085068","article-title":"Transcriptional regulation by the phosphorylation-dependent factor CREB","volume":"2","author":"Mayr","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2022061705134091000_bib21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/cas.12600","article-title":"In vivo imaging models of bone and brain metastases and pleural carcinomatosis with a novel human EML4-ALK lung cancer cell line","volume":"106","author":"Nanjo","year":"2015","journal-title":"Cancer Sci"},{"key":"2022061705134091000_bib22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1349-7006.2006.00163.x","article-title":"Novel orthotopic implantation model of human malignant pleural mesothelioma (EHMES-10 cells) highly expressing vascular endothelial growth factor and its receptor","volume":"97","author":"Nakataki","year":"2006","journal-title":"Cancer Sci"},{"key":"2022061705134091000_bib23","first-page":"5242","article-title":"Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma","volume":"62","author":"J\u00e4nne","year":"2002","journal-title":"Cancer Res"},{"key":"2022061705134091000_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1478-811X-11-47","article-title":"Phosphodiesterase activity is regulated by CC2D1A that is implicated in non-syndromic intellectual disability","volume":"11","author":"Al-Tawashi","year":"2013","journal-title":"Cell Commun Signal"},{"key":"2022061705134091000_bib25","doi-asserted-by":"crossref","first-page":"14644","DOI":"10.1074\/jbc.M111.261875","article-title":"Protein implicated in nonsyndromic mental retardation regulates protein kinase A (PKA) activity","volume":"287","author":"Al-Tawashi","year":"2012","journal-title":"J Biol Chem"},{"key":"2022061705134091000_bib26","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1158\/1078-0432.CCR-08-1137","article-title":"CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy","volume":"15","author":"Sakamoto","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2022061705134091000_bib27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ccr.2005.02.018","article-title":"The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia","volume":"7","author":"Shankar","year":"2005","journal-title":"Cancer Cell"},{"key":"2022061705134091000_bib28","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1158\/0008-5472.CAN-07-5376","article-title":"Cyclic AMP response element-binding protein overexpression: a feature associated with negative prognosis in never smokers with non\u2013small cell lung cancer","volume":"68","author":"Seo","year":"2008","journal-title":"Cancer Res"},{"key":"2022061705134091000_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.semcancer.2010.12.007","article-title":"Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment","volume":"21","author":"Braeuer","year":"2011","journal-title":"Semin Cancer Biol"},{"key":"2022061705134091000_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1615\/CritRevOncog.v16.i1-2.50","article-title":"CREB and leukemogenesis","volume":"16","author":"Cho","year":"2011","journal-title":"Crit Rev Oncog"},{"key":"2022061705134091000_bib31","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.2353\/ajpath.2009.090400","article-title":"Activated cAMP response element binding protein is overexpressed in human mesotheliomas and inhibits apoptosis","volume":"175","author":"Shukla","year":"2009","journal-title":"Am J Pathol"},{"key":"2022061705134091000_bib32","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.ajpath.2014.06.008","article-title":"CREB-induced inflammation is important for malignant mesothelioma growth","volume":"184","author":"Westbom","year":"2014","journal-title":"Am J Pathol"},{"key":"2022061705134091000_bib33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.arr.2010.02.004","article-title":"Protein kinase A signaling as an anti-aging target","volume":"9","author":"Enns","year":"2010","journal-title":"Ageing Res Rev"},{"key":"2022061705134091000_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1749-6632.2002.tb04332.x","article-title":"Protein kinase A as target for novel integrated strategies of cancer therapy","volume":"968","author":"Tortora","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"2022061705134091000_bib35","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1196\/annals.1281.028","article-title":"Clinical studies in patients with solid tumors using a second-generation antisense oligonucleotide (GEM 231) targeted against protein kinase A type I","volume":"1002","author":"Mani","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"2022061705134091000_bib36","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.cell.2011.10.039","article-title":"Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms","volume":"147","author":"Piskounova","year":"2011","journal-title":"Cell"},{"key":"2022061705134091000_bib37","first-page":"153","article-title":"Efficacy of recombinant adenoviral human p53 gene in treatment of malignant pleural or peritoneal effusions","volume":"16","author":"Zhang","year":"2013","journal-title":"Zhongguo Fei Ai Za Zhi"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/75\/19\/4188\/2724353\/4188.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/75\/19\/4188\/2724353\/4188.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T12:37:45Z","timestamp":1655469465000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/75\/19\/4188\/606339\/Akt-Kinase-Interacting-Protein-1-Signals-through"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,30]]},"references-count":37,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2015,9,30]]},"published-print":{"date-parts":[[2015,10,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-15-0858","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6506885.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22405598.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22405601.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22405601","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6506885","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22405598","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,30]]}}}